Oncotype DX® breast cancer assay may spare thousands of women from chemotherapy Medical Services Advisory Committee has now rejected five funding applications for Oncotype DX Melbourne, Australia, 4 October 2017: THE Federal Government’s peak advisory committee for Medicare funding has rejected calls from doctors, patients and the pharma industry to fund a novel breast cancer test
![Arctica Specialised Therapeutics](https://stabiopharma.com/wp-content/uploads/2021/03/stabio-logo.png)